Many potential applications of automation tools face data protection hurdles. At the FutureHealth conference series, ...

In today’s high-cost R&D environment, pharma success depends less on cost-cutting and more on evidence-based portfolio decisions, niche-buster strategies, and real-world data-driven indication ...

Moderately bullish activity in Moderna (MRNA), with shares up 18c, or 0.65%, near $28.55. Options volume roughly in line with average with 32k ...

How is SPY stock faring? The SPDR S&P 500 ETF Trust ($SPY) is up 0.83% over the past five days and has gained about 15.05% year-to-date. According ...

A substantial body of evidence supports the safety of the COVID-19 vaccines during pregnancy, contrary to the suggestions of ...

Former NIH director Francis Collins addressed over 1,0000 people at Spokane's Fox Theater Thursday night, discussing his journeys in science and Christianity, along with a polarization and lack of ...

Clinical studies suggest these vaccines can generate immunological memory, allowing lymphocytes to respond to tumor ...

The European Commission has on Friday signed a new joint procurement agreement with the Spanish pharmaceutical company HIPRA, ...

The company has also secured a coveted place in the global mRNA technology hub — one of just 15 vaccine makers worldwide in the network and only one from the country — enabling it to roll out new vacc ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Novo Nordisk’s Q2 2025 shows strong growth despite competition. See more on NVO's key catalysts and price targets driving ...